TruAlt Bioenergy · NSE: TRUALT · BSE: 544545
Q1 FY27 results · Apr–Jun 2026
TruAlt Bioenergy reported revenue from operations of ₹626.88 crore (up 106.3% from Q1 FY26) and net profit of ₹59.27 crore (up 1154.4% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 626.88 | 303.89 | +106.3% | 595.52 | +5.3% |
| Other income | 14.52 | 22.74 | −36.1% | 31.39 | −53.7% |
| Total income | 641.41 | 326.63 | +96.4% | 626.91 | +2.3% |
| Profit before tax | 78.45 | 5.80 | 14x | 83.70 | −6.3% |
| Net profit for the period | 59.27 | 4.73 | 13x | 60.95 | −2.8% |
| Attributable to shareholders of the company | 57.15 | 4.73 | 12x | 59.88 | −4.6% |
| EPS, basic (₹) | 6.67 | 0.67 | not comparable | 6.99 | −4.6% |
| Net margin (%) | 9.5 | 1.6 | 10.2 |
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 615.92 | 293.93 | +109.5% | 603.22 | +2.1% |
| Other income | 14.45 | 22.56 | −35.9% | 13.40 | +7.9% |
| Total income | 630.37 | 316.49 | +99.2% | 616.62 | +2.2% |
| Profit before tax | 73.31 | 0.13 | 556x | 79.00 | −7.2% |
| Net profit for the period | 55.01 | 0.03 | 2140x | 56.73 | −3.0% |
| EPS, basic (₹) | 6.41 | 0.00 | not comparable | 6.62 | −3.2% |
| Net margin (%) | 8.9 | 0.0 | 9.4 |
Consolidated
- Filed with BSE
- 28 Jul 2026, 21:06 IST
- Board meeting
- 28 Jul 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 28 Jul 2026, 21:06 IST
- Board meeting
- 28 Jul 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE